Announced Fri, 26 Jun · 19:47 IST
GTBL initiates arbitration against Optimus Drugs for about Rs 90 crore
Regulatory & Legal View source PDF
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.7%1-day move
₹390.30
prior close
₹393.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-1.5-1.9-1.1+1.7+1.7+1.6-1.1-1.9-6.0-7.0———
Up moveDown movePending
AI summary
Gujarat Themis Biosyn has initiated arbitration against Optimus Drugs Private for breaching a supply agreement. GTBL claims Rs 75 crore in break fees under Take-or-Pay obligations, Rs 23.8 lakh as interest on delayed payments, Rs 15 crore in damages, plus costs. Total claims about Rs 90.24 crore. The company expects no financial impact as it is the claimant seeking recovery.
Likely market impact
Positive if award favours GTBL; near-term impact limited as outcome is uncertain. Material disclosure under SEBI LODR.